Comprehensive clinical data indicate that oncogenic MYC is correlated with proline metabolism and tumorigenic potential in a subset of cancer cells, such as the aggressive subclass of luminal breast cancer.5 Also, some MYC-induced neoplastic phenotypes are attributed to MYC regulation of proline metabolism.48 This evidence concerns the gene MYC and breast cancer.